Correlation Between Avadel Pharmaceuticals and Emergent Biosolutions
Can any of the company-specific risk be diversified away by investing in both Avadel Pharmaceuticals and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avadel Pharmaceuticals and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avadel Pharmaceuticals PLC and Emergent Biosolutions, you can compare the effects of market volatilities on Avadel Pharmaceuticals and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avadel Pharmaceuticals with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avadel Pharmaceuticals and Emergent Biosolutions.
Diversification Opportunities for Avadel Pharmaceuticals and Emergent Biosolutions
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Avadel and Emergent is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Avadel Pharmaceuticals PLC and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and Avadel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avadel Pharmaceuticals PLC are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of Avadel Pharmaceuticals i.e., Avadel Pharmaceuticals and Emergent Biosolutions go up and down completely randomly.
Pair Corralation between Avadel Pharmaceuticals and Emergent Biosolutions
Given the investment horizon of 90 days Avadel Pharmaceuticals PLC is expected to under-perform the Emergent Biosolutions. But the stock apears to be less risky and, when comparing its historical volatility, Avadel Pharmaceuticals PLC is 1.52 times less risky than Emergent Biosolutions. The stock trades about -0.09 of its potential returns per unit of risk. The Emergent Biosolutions is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 831.00 in Emergent Biosolutions on August 30, 2024 and sell it today you would earn a total of 180.00 from holding Emergent Biosolutions or generate 21.66% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Avadel Pharmaceuticals PLC vs. Emergent Biosolutions
Performance |
Timeline |
Avadel Pharmaceuticals |
Emergent Biosolutions |
Avadel Pharmaceuticals and Emergent Biosolutions Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Avadel Pharmaceuticals and Emergent Biosolutions
The main advantage of trading using opposite Avadel Pharmaceuticals and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avadel Pharmaceuticals position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.Avadel Pharmaceuticals vs. Emergent Biosolutions | Avadel Pharmaceuticals vs. Bausch Health Companies | Avadel Pharmaceuticals vs. Neurocrine Biosciences | Avadel Pharmaceuticals vs. Teva Pharma Industries |
Emergent Biosolutions vs. Zoetis Inc | Emergent Biosolutions vs. Bausch Health Companies | Emergent Biosolutions vs. Neurocrine Biosciences | Emergent Biosolutions vs. Akanda Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |